![]() Aceragen Aceragen (formerly known as Idera Pharmaceuticals) is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates. | ![]() Biothera Biothera is a biotechnology company developing natural gluco polysaccharides that engage and direct natural innate immune systems. | ![]() F-star Biotechnology F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology. | |
Founding Date | Founding Date 1989 | Founding Date 1997 | Founding Date 2006 |
Type | Type Public | Type Private | Type Private |
Tags | |||
Locations | Locations Durham, US HQ | Locations Roseville, US HQ | Locations Cambridge, GB HQ Wien, AT Cambridge, US |
Employees | Employees 3642% decrease | Employees 542% increase | Employees 39 |
Financial | |||
Revenue (est.) | Revenue (est.) $4.9m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) £18.7m (FY, 2018) |
Net income | Net income ($23.4m) (FY, 2022) | Net income N/A | Net income (£2.6m) (FY, 2018) |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 1.6m (over 11 years ago) | Latest funding round $ 9.4m (over 12 years ago) |
Total funding raised | Total funding raised $ 13.8m | Total funding raised $ 5.1m | Total funding raised $ 57.3m |

Biothera is a biotechnology company developing natural gluco polysaccharides that engage and direct natural innate immune systems.
View company
F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.
View company